Ebola: How much will this cost us?

By the end of the year, it’s expected that more than 50 million people in the world will have died from the virus.

But the global response has been woefully inadequate, with many developing countries lagging behind.

In many parts of the world, healthcare systems have failed to cope with the massive numbers of infections, leaving the majority of patients unable to access basic healthcare.

This has left millions of people in desperate need of the vaccines that were developed in the US and other developed countries.

But for now, there is little that can be done to combat the spread of the virus outside the US.

In the US, the National Institutes of Health (NIH) has been forced to suspend some of its research projects.

Last year, the NIH awarded more than $5 billion to develop new vaccines, but the project was also criticized for not providing sufficient funding.

“The reason we have to stop funding is because of what we have learned,” NIH Director Francis Collins told the BBC.

“The US has made some progress, but we are not where we need to be.

And we will have to find new funding.

We have got to find the right way to fund this.”US President Donald Trump has said the government will not continue to provide the vaccines to developing countries, and that the NIH will stop funding research into the disease.

But, at the moment, the US is not investing enough in the development of the vaccine.

The US government is investing about $6 billion a year, and some US states, such as Texas, have already taken steps to invest more in their own vaccine projects.

For now, though, the vaccine can only be used in the developing world.

“We are very much focused on the US,” said Dr John Vetter, the director of the Johns Hopkins Bloomberg School of Public Health and director of vaccine development at Johns Hopkins.

“We know we are the only country in the developed world that has vaccine-based immunotherapy.

And the other countries have their own issues.”

The World Health Organization (WHO) has already launched a pilot program to help developing countries develop their own vaccines, which could lead to a rapid expansion of the programme.

The United Nations Development Programme (UNDP), which oversees the world’s poorest countries, is also looking at funding the vaccine for countries that are unable to secure enough funding.UNDP spokesperson Alisa Norgaard said the UNDP was working with countries that have not had the vaccine to find ways to fund the vaccine and bring it to the aid of those who need it most.

“When you look at the number of people that are out of the country, they have to go back to their villages to get it,” Norgan said.

“And we know there are very limited resources in the global community to help them get vaccines.”UNDP has also set up a vaccine centre in the Philippines, which aims to make the vaccine available in the country by the end, according to Norgard.

The WHO is currently in talks with the US government to try to secure a deal on how to allocate the funding to fund vaccines in developing countries.